Tuesday, July 04, 2017 11:35:21 AM
This means the medicinal cannabis company’s shares have jumped over 20% since this time last week.
Why has it jumped?
The rally in AusCann’s shares can be traced back to June 15 when the company announced the key appointment of Dr Danial Schecter as Chief Medical Advisor.
Since the day of this announcement, AusCann’s shares have climbed in excess of 30%.
Investors appear to be optimistic that the appointment of the international medical cannabis expert will help the company succeed in its medical outreach program.
The company aims for the program to educate Australian physicians about the benefits of medicinal cannabis, ultimately allowing them to make an informed decision on whether or how to prescribe cannabinoid medicines.
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM